Literature DB >> 21934068

Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses.

Wânia F Pereira1, Flávia L Ribeiro-Gomes, Landi V Costilla Guillermo, Natália S Vellozo, Fabrício Montalvão, George A Dosreis, Marcela F Lopes.   

Abstract

Th1/Th2 cytokines play a key role in immune responses to Leishmania major by controlling macrophage activation for NO production and parasite killing. MDSCs, including myeloid precursors and immature monocytes, produce NO and suppress T cell responses in tumor immunity. We hypothesized that NO-producing MDSCs could help immunity to L. major infection. Gr1(hi)(Ly6C(hi)) CD11b(hi) MDSCs elicited by L. major infection suppressed polyclonal and antigen-specific T cell proliferation. Moreover, L. major-induced MDSCs killed intracellular parasites in a NO-dependent manner and reduced parasite burden in vivo. By contrast, treatment with ATRA, which induces MDSCs to differentiate into macrophages, increased development of lesions, parasite load, and T cell proliferation in draining LNs. Altogether, these results indicate that NO-producing MDSCs help protective immunity to L. major infection, despite suppressed T cell proliferation.

Entities:  

Mesh:

Year:  2011        PMID: 21934068     DOI: 10.1189/jlb.1110608

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  28 in total

1.  Myeloid-derived suppressor cells control microbial sepsis.

Authors:  Marc Derive; Youcef Bouazza; Corentine Alauzet; Sébastien Gibot
Journal:  Intensive Care Med       Date:  2012-05-03       Impact factor: 17.440

Review 2.  Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology.

Authors:  Xi Chen; Yun Lu; Zhengguo Zhang; Jian Wang; Hui Yang; Guangwei Liu
Journal:  Immunology       Date:  2015-06-03       Impact factor: 7.397

3.  Protection by LPS-induced inhibitory CD11b(+) cells on corneal allograft.

Authors:  Yuping Han; Shaozhen Zhao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

Review 5.  Myeloid-Derived Suppressor Cells in Infection: A General Overview.

Authors:  Eva Medina; Dominik Hartl
Journal:  J Innate Immun       Date:  2018-06-26       Impact factor: 7.349

6.  Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.

Authors:  Syamdas Bandyopadhyay; Amrita Bhattacharjee; Sayantan Banerjee; Kuntal Halder; Shibali Das; Bidisha Paul Chowdhury; Subrata Majumdar
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

7.  Inhibition of caspase-8 activity promotes protective Th1- and Th2-mediated immunity to Leishmania major infection.

Authors:  Wânia F Pereira-Manfro; Flávia L Ribeiro-Gomes; Alessandra Almeida Filardy; Natália S Vellozo; Landi V C Guillermo; Elisabeth M Silva; Richard M Siegel; George A Dosreis; Marcela F Lopes
Journal:  J Leukoc Biol       Date:  2013-09-26       Impact factor: 4.962

8.  Retinoic acid inhibits CD25+ dendritic cell expansion and γδ T-cell activation in experimental autoimmune uveitis.

Authors:  Dongchun Liang; Aijun Zuo; Hui Shao; Willi K Born; Rebecca L O'Brien; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

Review 9.  Potential role of nuclear receptor ligand all-trans retinoic acids in the treatment of fungal keratitis.

Authors:  Hong-Yan Zhou; Wei Zhong; Hong Zhang; Miao-Miao Bi; Shuang Wang; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

10.  Primary Heligmosomoides polygyrus bakeri infection induces myeloid-derived suppressor cells that suppress CD4+ Th2 responses and promote chronic infection.

Authors:  R M Valanparambil; M Tam; A Jardim; T G Geary; M M Stevenson
Journal:  Mucosal Immunol       Date:  2016-04-13       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.